Numerate, Inc.

Artificial intelligence and machine learning have moved from buzzwords to long-term business strategies in biopharmaceutical drug development with hundreds of millions of dollars invested in individua

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Denali Teams With Sirion On

Scrip has formed a list of 18 artificial intelligence companies using novel technologies to discover drug targets, highlighting those with pharma partnerships or internal development pipelines that c

There is an artificial intelligence boom happening in the life sciences sector, says Guido Lanza, president and CEO of AI biotech company Numerate Inc. , but pharma and biotech are playing catch-up